Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis, performances and applications

Information

  • Patent Grant
  • 8080689
  • Patent Number
    8,080,689
  • Date Filed
    Wednesday, August 11, 2010
    13 years ago
  • Date Issued
    Tuesday, December 20, 2011
    12 years ago
Abstract
Disclosed are compounds represented by structural formula (I):
Description
BACKGROUND OF THE INVENTION

Antioxidants are employed to prevent oxidation in a wide range of materials, for example, plastics, elastomers, lubricants, petroleum based products (lubricants, gasoline, aviation fuels, and engine oils), cooking oil, cosmetics, processed food products, and the like. While many antioxidants exist, there is a continuing need for new antioxidants that have improved properties.


SUMMARY OF THE INVENTION

The present invention relates to compounds containing dual functionalities of aromatic amines and hindered phenols that can be useful as stabilizers for organic materials, lubricants and petroleum based products, plastics and elastomers, cosmetics, foods and cooking oils, and other materials. In particular, the present invention pertains to highly effective antioxidant macromolecules described herein. This invention also reports an improved, highly efficient and economical process for the synthesis of amine (nitrogen) and sterically hindered phenol containing dual functional macromolecules. The design of macromolecules in this invention can incorporate at least two antioxidant moieties having different reactivities. The present invention also discloses their superior antioxidant performance compared to presently used commercial antioxidants. This is demonstrated especially in both synthetic and petroleum base stocks (Group I, II and III). In general one unique feature and design of the antioxidants described herein is their improved solubility in many commercially available oils and lubricants compared with currently available antioxidants.


In one embodiment the present invention is a compound represented by structural formula (I):




embedded image


Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl. Each Rc is independently an optionally substituted alkyl or an optionally substituted alkoxycarbonyl. Rx is —H or an optionally substituted alkyl. Ry is —H or an optionally substituted alkyl. Each R′ is independently —H or an optionally substituted alkyl. R″ is —H, an optionally substituted alkyl, an optionally substituted aryl or an optionally substituted aralkyl. n is an integer from 1 to 10. m is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. u is an integer from 1 to 4. With the proviso that when n is 1, then either ring C is not:




embedded image



s is not 0, or R″ is not —H.


In another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a phenol derivative, an amine and an aldehyde in the presence of a solvent, wherein the phenol derivative comprises at least one unsubstituted ring-carbon atom. Followed by refluxing the combination to produce the compound, and finally isolating the compound.


In yet another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a amino-phenol derivative with an amine in the presence of a solvent, Followed by refluxing the combination to produce the compound, and finally isolating the compound.


In yet another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a phenolic-carbonyl derivative represented by the following structural formula:




embedded image



with an amine in the presence of a solvent. Followed by refluxing the combination to produce a Schiff's base, reducing the schiff's base with a reducing agent to produce the compound, and finally isolating the compound.


In another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a formaldehyde-sodium bisulfate adduct with an amine to produce a methylsulfonate sodium salt in an aqueous media. Followed by the nucleophilic displacement of the sulfonate group with a sodium or potassium salt of a phenol derivative, in an aqueous media wherein the nucleophilic displacement is catalyzed by base, to produce the compound, and finally isolating the compound.


In another embodiment the present invention is a method of preventing oxidation in an oxidizable material, comprising combining the oxidizable material with a compound of the present invention.


The antioxidants described herein which are prepared by the disclosed processes in general are superior antioxidants (compared to currently available antioxidants) against oxidative, thermal degradation of organic materials. These macromolecular antioxidants generally have comparatively higher antioxidant activities along with improved thermal stability and performance in a wide range of materials including but not limited to plastics, elastomers, lubricants, petroleum based products (lubricants, gasoline, aviation fuels, and engine oils), cooking oil, cosmetics, processed food products.


The processes of the present invention have many advantages which can allow improved synthesis of these macromolecular antioxidants. For example, the disclosed processes can be economically carried out in the melt phase without the presence of catalysts. Moreover, the processes described herein generally reduce or eliminate purification steps for the final product compared to existing syntheses, which can lead to a superior performance/cost ratio for the product and reduced amounts of waste.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.



FIG. 1, is a graph of Oxidative Induction Time (OIT) values of Structural Formula A of the invention versus Commercial antioxidants (AO's) in Group II Lubricating Oils.



FIG. 2, is a graph of the performance comparison of Oxidative Induction Time (OIT) values of commercial antioxidants versus antioxidants of the present invention in GII base oil at 200 ppm by differential scanning calorimetry (DSC).



FIG. 3, is a graph of commercial Irganox 1010 versus antioxidants of the present invention in polypropylene at 1000 ppm by DSC.





DETAILED DESCRIPTION OF THE INVENTION

A description of preferred embodiments of the invention follows.


As used herein, “dual functional” means any molecule with two functional groups which can optionally be the same or in certain embodiment are different, such as amine and hydroxy.


As used herein “adduct” means chemically linked.


Sterically hindered, as used herein means that the substituent group (e.g., bulky alkyl group) on a ring carbon atom adjacent (or para) to a ring carbon atom substituted with a phenolic hydroxy group (or thiol or amine group), is large enough to sterically hinder the phenolic hydroxy group (or thiol or amine groups). This steric hindrance, in certain embodiments results in more labile or weak bonding between the oxygen and the hydrogen (or sulfur or nitrogen and hydrogen) and in turn enhances the stability and antioxidant activity (proton donating activity) of the sterically hindered antioxidant.


Repeat units of the antioxidants of the invention include substituted benzene molecules. Some of these benzene molecules are typically based on phenol or a phenol derivative, such that they have at least one hydroxyl or ether functional group. In certain embodiments, the benzene molecules have a hydroxyl group. The hydroxyl group can be a free hydroxyl group and can be protected or have a cleavable group attached to it (e.g., an ester group). Such cleavable groups can be released under certain conditions (e.g., changes in pH), with a desired shelf life or with a time-controlled release (e.g., measured by the half-life), which allows one to control where and/or when an antioxidant can exert its antioxidant effect. The repeat units can also include analogous thiophenol and aniline derivatives, e.g., where the phenol —OH can be replaced by —SH, —NH—, and the like.


Substituted benzene repeat units of an antioxidant of the invention are also typically substituted with a bulky alkyl group or an n-alkoxycarbonyl group. In certain embodiments, the benzene monomers are substituted with a bulky alkyl group. In certain other embodiments, the bulky alkyl group is located ortho or meta to a hydroxyl group on the benzene ring, typically ortho. A “bulky alkyl group” is defined herein as an alkyl group that is branched alpha- or beta- to the benzene ring. In certain other embodiments, the alkyl group is branched alpha to the benzene ring. In certain other embodiments, the alkyl group is branched twice alpha to the benzene ring, such as in a tert-butyl group. Other examples of bulky alkyl groups include isopropyl, 2-butyl, 3-pentyl, 1,1-dimethylpropyl, 1-ethyl-1-methylpropyl and 1,1-diethylpropyl. In certain other embodiments, the bulky alkyl groups are unsubstituted, but they can be substituted with a functional group that does not interfere with the antioxidant activity of the molecule. Straight chained alkoxylcarbonyl groups include methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, n-butoxycarbonyl and n-pentoxycarbonyl. N-propoxycarbonyl is a preferred group. Similar to the bulky alkyl groups, n-alkoxycarbonyl groups are optionally substituted with a functional group that does not interfere with the antioxidant activity of the molecule.


In one embodiment the present invention is a compound represented by structural formula (I) wherein the variables are as described as follows:


Each Ra is independently an optionally substituted alkyl. In one embodiment, each Ra is independently a C1-C20 alkyl. In another embodiment, each Ra is independently a C1-C10 alkyl. In another embodiment, each Ra is independently selected from the group consisting of:




embedded image


In another embodiment Ra is:




embedded image


Each Rb is independently an optionally substituted alkyl.


Each Rc is independently an optionally substituted alkyl or an optionally substituted alkoxycarbonyl. In one embodiment, each Rc is independently a C1-C10 alkyl.


Rx is —H or an optionally substituted alkyl. Ry is —H or an optionally substituted alkyl. In one embodiment, Rx and Ry are —H.


Each R′ is independently —H or an optionally substituted alkyl. In one embodiment, one R′ is —H. In another embodiment, both R′ are —H.


R″ is —H, an optionally substituted alkyl, an optionally substituted aryl or an optionally substituted aralkyl. In one embodiment, R″ is —H, a C1-C20 alkyl or an optionally substituted aralkyl. In another embodiment, R″ is —H, a C1-C10 alkyl or a substituted benzyl group. In yet another embodiment, R″ is —H. In yet another embodiment, R″ is:




embedded image



In yet another embodiment R″ is selected from the group consisting of:




embedded image


In yet another embodiment R″ is:




embedded image


n is an integer from 1 to 10. In one embodiment, n is an integer from 1 to 6. In another embodiment, n is 1. In yet another embodiment, n is 2. In yet another embodiment, n is 3. In yet another embodiment, n is 4.


m is an integer from 1 to 10. In one embodiment, m is 1 or 2. In another embodiment, m is 1.


s is an integer from 0 to 5. In one embodiment, s is 0 or 1. In another embodiment, s is 0.


t is an integer from 0 to 4. In one embodiment, t is 0.


u is an integer from 1 to 4. In one embodiment, u is 1 or 2.


In certain embodiments for compounds of the present invention, including those represented by structural formula (I), when n is 1, the either ring C is not:




embedded image



s is not 0, or R″ is not —H.


In one embodiment of the present invention for the compounds represented by structural formula (I):


Each Ra is independently a C1-C20 alkyl. Each Rc is independently a C1-C10 alkyl. R″ is —H, a C1-C20 alkyl or an optionally substituted aralkyl, and the remainder of the variables are as described above for structural formula (I).


In another embodiment of the present invention for compounds represented by structural formula (I): one R′ is —H, t is 0, Rx and Ry are —H and the compounds are represented by structural formula (II):




embedded image



and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I).


In another embodiment of the present invention for the compounds represented by structural formula (II):


m is 1 or 2.


s is 0 or 1.


u is 1 or 2, and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I).


In another embodiment of the present invention for compounds represented by structural formula (II): both R′ are —H and m is 1 and the compounds are represented by structural formula (III):




embedded image



and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I) or (II).


In another embodiment of the present invention for the compounds represented by structural formula (III):


Each Ra is independently a C1-C10 alkyl.


R″ is —H, a C1-C10 alkyl or a substituted benzyl group.


n is an integer from 1 to 6, and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I) or (II).


In another embodiment of the present invention for compounds represented by structural formula (III): n is 1, s is 0 and R″ is —H and the compounds are represented by structural formula (IV):




embedded image



with the proviso that ring C is not:




embedded image



and the remainder of the variables are as described above for structural formula (I), (II) or (III).


In certain embodiments of the present invention the compounds represented by structural formula (III) or (IV) are represented by the following structural formulas:




embedded image


In another embodiment of the present invention for compounds represented by structural formula (III): n is 1 and the compounds are represented by structural formula (V):




embedded image



and the remainder of the variables are as described above for structural formula (I), (II) or (III).


In another embodiment of the present invention for compounds represented by structural formula (III): s is 0 and the compounds are represented by structural formula (VI):




embedded image



and the remainder of the variables are as described above for structural formula (I), (II) or (III).


In another embodiment of the present invention for compounds represented by structural formula (III): R″ is —H and the compounds are represented by structural formula (VII):




embedded image



and the remainder of the variables are as described above for structural formula (I), (II) or (III).


In certain embodiments of the present invention the compounds represented by structural formula (III), (V), (VI) or (VII) are represented by the following structural formulas:




embedded image


embedded image


embedded image


embedded image


embedded image


In another embodiment of the present invention for compounds represented by structural formula (III): R″ is —H and n is 1 and the compounds are represented by structural formula (VIII):




embedded image



and the remainder of the variables are as described above for structural formula (I), (II) or (III).


In certain embodiments of the present invention the compounds represented by structural formula (III) or (VIII) are represented by the following structural formulas:




embedded image


embedded image


In another embodiment of the present invention for compounds represented by structural formula (III): s is 0 and R″ is —H and the compounds are represented by structural formula (IX):




embedded image



and the remainder of the variables are as described above for structural formula (I), (II) or (III).


In certain embodiments of the present invention the compounds represented by structural formula (III) or (IX) are represented by the following structural formulas:




embedded image


In another embodiment of the present invention for compounds represented by structural formula (III): s is 0 and n is 0 and the compounds are represented by structural formula (X):




embedded image



and the remainder of the variables are as described above for structural formula (I), (II) or (III).


In certain embodiments of the present invention the compounds represented by structural formula (III) or (X) are represented by the following structural formulas:




embedded image


In another embodiment of the present invention the compound is represented by:




embedded image


embedded image


embedded image


The term “alkyl” as used herein means a saturated straight-chain, branched or cyclic hydrocarbon. When straight-chained or branched, an alkyl group is typically C1-C20, more typically C1-C10; when cyclic, an alkyl group is typically C3-C12, more typically C3-C7. Examples of alkyl groups include methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl and tent-butyl and 1,1-dimethylhexyl.


The term “alkoxy” as used herein is represented by —OR**, wherein R** is an alkyl group as defined above.


The term “carbonyl” as used herein is represented by —C(═O)R**, wherein R** is an alkyl group as defined above.


The term “alkoxycarbonyl” as used herein is represented by —C(═O)OR**, wherein R** is an alkyl group as defined above.


The term “aromatic group” includes carbocyclic aromatic rings and heteroaryl rings. The term “aromatic group” may be used interchangeably with the terms “aryl”, “aryl ring” “aromatic ring”, “aryl group” and “aromatic group”.


Carbocyclic aromatic ring groups have only carbon ring atoms (typically six to fourteen) and include monocyclic aromatic rings such as phenyl and fused polycyclic aromatic ring systems in which a carbocyclic aromatic ring is fused to one or more aromatic rings (carbocyclic aromatic or heteroaromatic). Examples include 1-naphthyl, 2-naphthyl, 1-anthracyl and 2-anthracyl, Also included within the scope of the term “carbocyclic aromatic ring”, as it is used herein, is a group in which an aromatic ring is fused to one or more non-aromatic rings (carbocyclic or heterocyclic), such as in an indanyl, phthalimidyl, naphthimidyl, phenanthridinyl, or tetrahydronaphthyl.


The term “heteroaryl”, “heteroaromatic”, “heteroaryl ring”, “heteroaryl group” and “heteroaromatic group”, used alone or as part of a larger moiety as in “heteroaralkyl” refers to heteroaromatic ring groups having five to fourteen members, including monocyclic heteroaromatic rings and polycyclic aromatic rings in which a monocyclic aromatic ring is fused to one or more other aromatic ring (carbocyclic or heterocyclic). Heteroaryl groups have one or more ring heteroatoms. Examples of heteroaryl groups include 2-furanyl, 3-furanyl, N-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, oxadiazolyl, oxadiazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, N-pyrazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, N-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 3-pyridazinyl, 4-pyridazinyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, triazolyl, tetrazolyl, 2-thienyl, 3-thienyl, carbazolyl, benzothienyl, benzofuranyl, indolyl, quinolinyl, benzothiazole, benzooxazole, benzimidazolyl, isoquinolinyl and isoindolyl. Also included within the scope of the term “heteroaryl”, as it is used herein, is a group in which an aromatic ring is fused to one or more non-aromatic rings (carbocyclic or heterocyclic).


The term non-aromatic heterocyclic group used alone or as part of a larger moiety refers to non-aromatic heterocyclic ring groups having three to fourteen members, including monocyclic heterocyclic rings and polycyclic rings in which a monocyclic ring is fused to one or more other non-aromatic carbocyclic or heterocyclic ring or aromatic ring (carbocyclic or heterocyclic). Heterocyclic groups have one or more ring heteroatoms, and can be saturated or contain one or more units of unsaturation. Examples of heterocyclic groups include piperidinyl, piperizinyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, tetrahydroquinolinyl, inodolinyl, isoindolinyl, tetrahydrofuranyl, oxazolidinyl, thiazolidinyl, dioxolanyl, dithiolanyl, tetrahydropyranyl, dihydropyranyl, azepanyl and azetidinyl


The term “heteroatom” means nitrogen, oxygen, or sulfur and includes any oxidized form of nitrogen and sulfur, and the quaternized form of any basic nitrogen. Also the term “nitrogen” includes a substitutable nitrogen of a heteroaryl or non-aromatic heterocyclic group. As an example, in a saturated or partially unsaturated ring having 0-3 heteroatoms selected from oxygen, sulfur or nitrogen, the nitrogen may be N (as in 3,4-dihydro-2H-pyrrolyl), NH (as in pyrrolidinyl) or NR″ (as in N-substituted pyrrolidinyl), wherein R″ is a suitable substituent for the nitrogen atom in the ring of a non-aromatic nitrogen-containing heterocyclic group, as defined below. Preferably the nitrogen is unsubstituted.


As used herein the term non-aromatic carbocyclic ring as used alone or as part of a larger moiety refers to a non-aromatic carbon containing ring which can be saturated or contain one or more units of unsaturation, having three to fourteen atoms including monocyclic and polycyclic rings in which the carbocyclic ring can be fused to one or more non-aromatic carbocyclic or heterocyclic rings or one or more aromatic (carbocyclic or heterocyclic) rings


An optionally substituted aryl group as defined herein may contain one or more substitutable ring atoms, such as carbon or nitrogen ring atoms, Examples of suitable substituents on a substitutable ring carbon atom of an aryl group include halogen (e.g., —Br, Cl, I and F), —OH, C1-C4 alkyl, C1-C4 haloalkyl, —NO2, C1-C4 alkoxy, C1-C4 haloalkoxy, —CN, —NH2, C1-C4 alkylamino, C1-C4 dialkylamino, —C(O)NH2, —C(O)NH(C1-C4 alkyl), —C(O)(C1-C4 alkyl), —OC(O)(C1-C4 alkyl), —OC(O)(aryl), —OC(O)(substituted aryl), —OC(O)(aralkyl), —OC(O)(substituted aralkyl), —NHC(O)H, —NHC(O)(C1-C4 alkyl), —C(O)N(C1-C4 alkyl)2, —NHC(O)O—(C1-C4 alkyl), —C(O)OH, —C(O)O—(C1-C4 alkyl), —NHC(O)NH2, —NHC(O)NH(C1-C4 alkyl), —NHC(O)N(C1-C4 alkyl)2, —NH—C(═NH)NH2, —SO2NH2—SO2NH(C1-C3alkyl), —SO2N(C1-C3alkyl)2, NHSO2H, NHSO2(C1-C4 alkyl) and optionally substituted aryl. Preferred substituents on aryl groups are as defined throughout the specification, In certain embodiments aryl groups are unsubstituted.


Examples of suitable substituents on a substitutable ring nitrogen atom of an aryl group include C1-C4 alkyl, NH2, C1-C4 alkylamino, C1-C4 dialkylamino, —C(O)NH2, —C(O)NH(C1-C4 alkyl), —C(O)(C1-C4 alkyl), —CO2R**, —C(O)C(O)R**, —C(O)CH3, —C(O)OH, —C(O)O—(C1-C4 alkyl), —SO2NH2—SO2NH(C1-C3alkyl), —SO2N(C1-C3alkyl)2, NHSO2H, NHSO2(C1-C4 alkyl), —C(═S)NH2, —C(═S)NH(C1-C4 alkyl), —C(—S)N(C1-C4 alkyl)2, —C(NH)—N(H)2, —C(—NH)—NH(C1-C4 alkyl) and —C(═NH)—N(C1-C4 alkyl)2.


An optionally substituted alkyl group or non-aromatic carbocyclic or heterocyclic group as defined herein may contain one or more substituents. Examples of suitable substituents for an alkyl group include those listed above for a substitutable carbon of an aryl and the following: ═O, ═S, ═NNHR**, ═NN(R**)2, —NNHC(O)R**, —NNHCO2 (alkyl), ═NNHSO2 (alkyl), ═NR**, Spiro cycloalkyl group or fused cycloalkyl group. R** in each occurrence, independently is —H or C1-C6 alkyl. Preferred substituents on alkyl groups are as defined throughout the specification. In certain embodiments optionally substituted alkyl groups are unsubstituted.


A “spiro cycloalkyl” group is a cycloalkyl group which shares one ring carbon atom with a carbon atom in an alkylene group or alkyl group, wherein the carbon atom being shared in the alkyl group is not a terminal carbon atom.


In yet another embodiment, the present invention is a method of producing a compound described herein. The method comprises the steps of combining a phenol derivative, an amine and an aldehyde in the presence of a solvent, wherein the phenol derivative comprises at least one unsubstituted ring-carbon atom. Refluxing the combination of the phenol derivative, amine and aldehyde to produce the compound, and isolating the compound.


In certain embodiments of the present invention, the phenol derivative is represented by the following structural formula:




embedded image



Each Rc is independently an optionally substituted alkyl or optionally substituted alkoxycarbonyl. R′ is —H or an optionally substituted alkyl. u is an integer from 1 to 4. Additional values for these variables are as described above. In one embodiment the phenol derivative is selected from:




embedded image


In another embodiment, the amine is represented by the following structural formula:




embedded image


Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl. Each R′ is independently —H or an optionally substituted alkyl. n is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. Additional values for these variables are as described above.


In certain embodiments the aldehyde used in the methods of the present invention is selected from the group consisting of paraformaldehyde, formaldehyde, butylaldehyde and nonaldehyde.


In certain embodiments the solvent used in the methods of the present invention is selected from the group consisting of methanol, butanol, ethanol and toluene.


In certain embodiments of the present invention after combining the amine, aldehyde and phenol derivative in a suitable solvent the combination is refluxed for between 1 and 48 hours, between 6 and 32 hours or between 12 and 24 hours with optional stirring. In certain embodiments the combination is refluxed at a temperature between 20 and 250° C., between 60 and 180° C. or between 100 and 120° C.


In certain embodiments of the present invention equimolar amounts of the phenol derivative and the amine are combined. In certain embodiments of the present invention the phenol derivative and the amine are combined an a 1:0.5, 1:1.2, 1:1.5, 1:1.0 molar ratio of phenol derivative:amine.


The following schemes illustrate particular embodiments of this method:




embedded image


Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.




embedded image


Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.




embedded image


Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.




embedded image


Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.


In one embodiment of the present invention the following schemes illustrate the methods described above:




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image


The variables R and R1-8 described herein correspond to the variables described above for structural formulas (I) through (X) as follows R1-4 are equivalent to Rb, R5-8 are equivalent to Rc, R is equivalent to Ra, and n and m are the same.


In yet another embodiment the present invention is a method of producing a compound described herein. The method comprises the steps of combining an amino-phenol derivative with an amine in the presence of a solvent. Refluxing the combination to produce the compound, and isolating the compound.


In certain embodiments of the present invention the amino-phenol derivative is represented by the following structural formula:




embedded image



Each Rc is independently an optionally substituted alkyl or an optionally substituted alkoxycarbonyl. R′ is —H or an optionally substituted alkyl. R** is an optionally substituted alkyl. o is an integer from 1 to 10. u is an integer from 1 to 4. Additional values for these variables are as described above. In another embodiment the amino-phenol is selected from the group consisting of:




embedded image


In another embodiment, the amine is represented by the following structural formula:




embedded image


Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl, Each R′ is independently —H or an optionally substituted alkyl. In certain embodiments one R′ is —H—H and the second R′ is —H or an optionally substituted alkyl, n is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. Additional values for these variables are as described above.


In certain embodiments, in the methods of the present invention the solvent is selected from the group consisting of toluene, methanol, ethanol and butanol.


In certain other embodiments of the present invention after combining the amine and amino-phenol derivative in a suitable solvent the combination is refluxed at a temperature between 50 and 180° C., between 90 and 130° C., between 100 and 110° C. In certain embodiments, the combination is refluxed for between 1 and 48 hours, between 6 and 36 hours, between 12 and 24 hours or between 18 and 20 hours.


In certain embodiments of the present invention equimolar amounts of the amino-phenol derivative and the amine are combined. In certain embodiments of the present invention the amino-phenol derivative and the amine are combined an a 1:0.5, 1:1.2, 1:1.5, 1:1.0 molar ratio of amino-phenol derivative:amine.


In one embodiment the above method can be conducted in one step and can be conducted without catalyst. The process can be conducted by mixing two starting components in a suitable solvent and heating the reaction mixture to reflux as shown in Scheme E:




embedded image


The variables are as described above.


In one embodiment, the above method involves mixing of sterically hindered phenolic acid derivatives, preferably 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol with substituted amines e.g., N-phenyl-1,4-phenylene-diamine in a suitable solvent. The solvent can be a single solvent or mixture of two solvents. In another embodiment, the solvent is toluene.


One embodiment of the present invention is directed to combining equimolar amounts of the starting components, e.g., 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol and N-phenyl-1,4-phenylene-diamine, in toluene and refluxing the reaction mixture at, e.g., 100° C.


In certain embodiment the methods of the present invention are simple, efficient, economical and can be conducted without catalyst.


In certain other embodiments in the methods of the present invention, when solvent is used it can be recycled by separating the solvents from the reaction mixture using distillation.


In one embodiment, the present invention relates to a process or processes for the preparation of macromolecule antioxidants represented by Structural Formula I:




embedded image


The disclosed synthesis of macromolecules (I) can be conducted in one step and can be conducted without catalyst. The process can be conducted by mixing two starting components in a suitable solvent and heating the reaction mixture to reflux as shown in Scheme 1.




embedded image


The disclosed process can involve mixing of sterically hindered phenolic acid derivatives, preferably 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (III) with substituted amines e.g., N-phenyl-1,4-phenylene-diamine (II) in a suitable solvent. The solvent can be a single solvent or mixture of two solvents. The preferred solvent for the process can be toluene. The preferred method can be mixing of equimolar amounts of the starting components, e.g., 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol and N-phenyl-1,4-phenylene-diamine, in toluene and refluxing the reaction mixture at, e.g., 100° C. The disclosed process can be simple, efficient, economical and can be conducted without catalyst. Further, when solvent is used in the process, it can be recycled by separating the solvents from the reaction mixture using distillation Moreover, the above mentioned reaction can also be performed under solvent-less conditions, at 100-180° C., preferably at 110° C.


In yet another embodiment the present invention is a method of producing a compound described herein. The method comprises the steps of combining a phenolic-carbonyl derivative represented by the following structural formula:




embedded image



with an amine in the presence of a solvent. Refluxing the combination of phenolic-carbonyl and amine to produce a schiff's base. Reducing the schiff's base with a reducing agent to produce the compound, and isolating the compound. o is an integer from 0 to 10. R* is —H or an optionally substituted alkyl. Additional values for the variables are as described above. In certain embodiments the phenolic carbonyl is selected from the group comprising:




embedded image


In another embodiment, the amine is represented by the following structural formula:




embedded image


Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl. Each R′ is independently —H or an optionally substituted alkyl. n is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. Additional values for these variables are as described above.


In certain embodiments of the present invention the solvent is selected from the group consisting of toluene, methanol, ethanol and butanol.


In certain other embodiments of the present invention after combining the amine and phenolic-carbonyl derivative in a suitable solvent the combination is refluxed at a temperature between 50 and 180° C., between 60 and 130° C., between 70 and 110° C. In certain embodiments, the combination is refluxed for between 1 and 48 hours, between 6 and 36 hours, between 12 and 24 hours or between 18 and 20 hours.


In certain embodiments of the present invention equimolar amounts of the phenol-carbonyl derivative and the amine are combined. In certain embodiments of the present invention the amino-phenol derivative and the amine are combined an a 1:0.5, 1:1.2, 1:1.5, 1:1.0 molar ratio of phenol-carbonyl derivative:amine


In certain embodiment the reducing agent is selected from the groups consisting of sodium borohydride, sodium cyanoborohydride and lithium aluminum hydride. In certain other embodiments reduction takes place via catalytic hydrogenation. In certain embodiments the catalytic hydrogenation agents are Pd—C or Raney Ni.


In yet another embodiment the present invention is a method of producing a compound described herein. The method comprises the steps of combining a formaldehyde-sodium bisulfite adduct with an amine to produce a methylsulfonate sodium salt in an aqueous media. Followed by the nucleophilic displacement of the sulfonate group with sodium or potassium salt of a phenol derivative, in an aqueous media, to produce the compound, and finally isolating the compound. In certain embodiments the nucleophilic displacement is promoted by base or catalyzed base. In certain embodiments, both combination steps are carried out in an aqueous media.


In certain embodiments the formaldehyde-sodium bisulfite adduct is HO—CH2—SO3Na.


In certain embodiments the methylsulfonate sodium salt is 4-(phenylamino)phenylamino methylsulfonate sodium salt.


In certain embodiments, the phenol derivative and amine are as described above.


In certain embodiments, the aqueous media is water.


In certain embodiments, the base is sodium hydroxide or potassium hydroxide.


In one embodiments of the present invention, the compound is not:




embedded image


The compounds of the present invention can be used as antioxidants to inhibit oxidation of an oxidizable material. Such as, for example to increase the shelf life of an oxidizable material.


The antioxidant compounds of the present invention can be employed to inhibit the oxidation of an oxidizable material, for example by contacting the material with an antioxidant compound made by the methods of the present invention.


For purposes of the present invention, a method of “inhibiting oxidation” is a method that inhibits the propagation of a free radical-mediated process. Free radicals can be generated by heat, light, ionizing radiation, metal ions and some proteins and enzymes. Inhibiting oxidation also includes inhibiting reactions caused by the presence of oxygen, ozone or another compound capable of generating these gases or reactive equivalents of these gases.


As used herein the term “oxidizable material” is any material which is subject to oxidation by free-radicals or oxidative reaction caused by the presence of oxygen, ozone or another compound capable of generating these gases or reactive equivalents thereof. In particular the oxidizable material is a lubricant or a mixture of lubricants.


The shelf life of many materials and substances contained within the materials, such as packaging materials, are enhanced by the presence of the antioxidants of the present invention. The addition of an antioxidant of the present invention to a packaging material is believed to provide additional protection to the product contained inside the package. In addition, the properties of many packaging materials themselves, particularly polymers, are enhanced by the presence of an antioxidant regardless of the application (i.e., not limited to use in packaging). Common examples of packaging materials include paper, cardboard and various plastics and polymers. A packaging material can be coated with an antioxidant (e.g., by spraying the antioxidant or by applying as a thin film coating), blended with or mixed with an antioxidant, or otherwise have an antioxidant present within it. In one example, a thermoplastic such as polyethylene, polypropylene or polystyrene can be melted in the presence of an antioxidant in order to minimize its degradation during the polymer processing.


The lifetime of lubricants, lubricant oils, mixtures thereof and compositions comprising lubricants and lubricant oils in general can be improved by contacting the lubricant, lubricant oil, mixtures thereof or composition comprising the lubricant or lubricant oil or mixtures thereof with compounds of the present invention, as described herein.


As used here, the terms “lubricants” and “lubricant oils” can be used interchangeably. Examples of lubricants suitable for use in the compositions and methods of the present invention include, but are not limited to: i) petroleum based oils (Group I, II and III), ii) synthetic oils (Group IV) and iii) biolubricant oils (vegetable oils such as canola, soybean, corn oil etc.). Group I oils, as defined herein are solvent refined base oils. Group II oils, as defined herein are modern conventional base oils made by hydrocracking and early wax isomerization, or hydroisomerization technologies and have significantly lower levels of impurities than Group I oils. Group III oils, as defined herein are unconventional base oils. Groups I-III differ in impurities, and viscosity index as is shown in Kramer et al. “The Evolution of Base Oil Technology” Turbine Lubrication in the 21st Century ASTM STP #1407 W. R. Herguth and T. M. Wayne, Eds., American Society for Testing and Materials, West Conshohocken, Pa., 2001 the entire contents of which are incorporated herein by reference. Group IV oils as defined herein are “synthetic” lubricant oils, including for example, poly-alpha olefins (PAOs). Biolubricants as defined herein are lubricants which contain at least 51% biomaterial (see Scott Fields, Environmental Health Perspectives, volume 111, number 12, September 2003, the entire contents of which are incorporated herein by reference). Other examples of lubricant oils cane be found in Melvyn F. Askew “Biolubricants-Market Data Sheet” IENICA, August 2004 (as part of the IENICA workstream of the IENICA-INFORRM project); Taylor et al. “Engine lubricant Trends Since 1990” paper accepted for publication in the Proceedings I. Mech. E. Part J, Journal of Engineering Tribology, 2005 (Vol. 219 p 1-16); and Desplanches et al. “Formulating Tomorrow's Lubricants” page 49-52 of The Paths to Sustainable Development, part of special report published in October 2003 by Total; the entire contents of each of which are incorporated herein by reference. Biolubricants are often but not necessarily, based on vegetable oils. Vegetable derived, for example, from rapeseed, sunflower, palm and coconut can be used as biolubricants. They can also be synthetic esters which may be partly derived from renewable resources. They can be made from a wider variety of natural sources including solid fats and low grade or waste materials such as tallows. Biolubricants in general offer rapid biodegradability and low environmental toxicity.


As used herein, Group I, II and III oils are petroleum base stock oil. The petroleum industry differentiates their oil based on viscosity index and groups them as Group I, II and III.


In certain embodiments of the present invention, 50% to 20% by weight of the antioxidants of the present invention are added to lubricant oils. In certain other embodiments of the present invention, 10% to 5% by weight of the antioxidants of the present invention are added to lubricant oils. In certain other embodiments of the present invention, 0.1% to 2% by weight of the antioxidants of the present invention are added to lubricant oils. In certain other embodiments of the present invention, 0.001% to 0.5% by weight of the antioxidants of the present invention are added to lubricant oils. This percentage varies depending upon their end application and type of the base oil.


In certain embodiments of the present invention the antioxidants of the present invention are usually added to lubricant oils with stirring at between 0 and 100° C., between 20 and 80° C. or between 40-60° C.


The macromolecules of the present invention can also be made by alkylation of substituted amines, most preferably, N-phenyl-1,4-phenylene-diamine (II) in a suitable solvent by benzyl halides, e.g., preferably 3,5-di-tert-butyl-4-hydroxy benzyl chloride (IV) or 3,5-di-tert-butyl-4-hydroxy benzyl bromide (V) as shown in Scheme 2.




embedded image


EXEMPLIFICATION
Example 1
Illustration of One Pot Process of Making Macromolecules of the Present Invention in Large Scale



embedded image



2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (26.3 g) and N-Phenyl-1,4-phenylene-diamine (18.4 g) were dissolved in 50 ml toluene. The reaction mixture was refluxed at 100° C. using a Dean Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The product (A) was characterized using spectroscopic techniques such as high resolution 1H NMR, 13C NMR and FT-IR.


Example 2
Performance of Macromolecules of the Present Invention in Lubricating Oils



embedded image


Macromolecule A was mixed with oil at 60° C. for 5-15 minutes at 200 ppm in petroleum based group II base stock oil and polyol based Group V base stock oils. It was tested using differential scanning calorimetry (DSC). Its Oxidative Induction Time (OIT) was also compared with commercially used antioxidants 2,6-di-tert-butyl-phenol, Naugalube APAN (PANA) and Vanlube 81 (DODP). FIG. 1 shows the macromolecule A is superior in protecting lubricating oils against oxidation.


Example 3
One Pot Process of Making Compound Having Structure I



embedded image



2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (3 g) and N-Phenyl-1,4-phenylene-diamine (2 g) were dissolved in 100 ml toluene. The reaction mixture was refluxed at 100° C. using a Dean's Stark apparatus equipped with a condenser. The reaction was monitored by thin layer chromatography. After completion, the solvent was removed by distillation and the resultant mixture was purified by column chromatography. The purified compound was characterized by spectroscopic techniques.


Example 4
One Pot Process of Making Compound Having Structure II



embedded image


2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (32 g) and N-Phenyl-1,4-phenylene-diamine (18.4 g) were dissolved in 50 ml toluene. The reaction mixture was refluxed at 100° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The purified compound was characterized by spectroscopic techniques.


Example 5
One Pot Process of Making Structure V



embedded image



2,6-di-tort-butyl phenol (10.3 g), paraformaldehyde (1.8 g) and N-hexyl-Phenyl-1,4-phenylene-diamine (16.08 g) were dissolved in 75 ml methanol. The reaction mixture was refluxed at 70° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The purified compound was characterized by spectroscopic techniques.


Example 6
One Pot Process of Making Structure X at



embedded image


2-methyl, 6-tert-butyl phenol (16.4 g), paraformaldehyde (3.6 g) and N-Phenyl-1,4-phenylene-diamine (22 g) were dissolved in 50 ml methanol, The reaction mixture was refluxed at 70° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration and purified by column chromatography. The purified compound was characterized by spectroscopic techniques.


Example 7
One Pot Process of Making Structure XVIII



embedded image



2,4-di-tert-butyl phenol (20.6 g), paraformaldehyde (3.6 g) and N-Phenyl-1,4-phenylene-diamine (22 g) were dissolved in 50 ml methanol. The reaction mixture was refluxed at 70° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The purified compound was characterized by spectroscopic techniques.


Example 8
Performance of Macromolecules of the Present Invention in Lubricating Oils



embedded image




embedded image



Macromolecules V and A were tested for their performance in lubricant oils and polymers. The macromolecules were mixed in oil with stirring at 60° C. for 5-15 mins at 200 ppm in petroleum based Group II base stock and polyol based Group V base stock oils. The performance of these antioxidants were evaluated in lubricant base oil stocks including Group II using the DSC technique for determining their oxidation induction times measured in minutes (OTT) at 200° C. The OITs of the antioxidants having structures V and A were compared with commercial antioxidants [L57: Ciba's Irganox L57, 6PPD: N-hexyl phenyl-1,4-phenylene diamine CAS # 793-24-8)]. The results are shown in FIG. 2 which shows the superior performance of V and A.


Macromolecule I, II, X and VIII are mixed in oil with stirring at 60° C. for 5-15 mins at 200 ppm in petroleum based Group II base stock and polyol based Group V base stock oils. The performance of these antioxidants is evaluated in lubricant base oil stocks including Group II using the DSC technique for determining their oxidation induction times measured in minutes (OTT) at 200° C. The OITs of these novel antioxidants having structures I, II, X, XVIII is compared with commercial antioxidants [L57: Ciba's Irganox L57, dioctylated diphenyl amine (DODP, CAS# 68411-46-1); 6PPD: N-hexyl phenyl-1,4-phenylene diamine CAS # 793-24-8)].


The summary of performance of antioxidants I, II, V, X, XVIII and A and their comparison with commercial antioxidants L 57 and 6PPD in synthetic polyol ester based oil is shown in Table 1. The macromolecules were mixed in oil with stirring at 60° C. for 5-15 mins at 200 ppm in petroleum based Group II base stock and polyol based Group V base stock oils. Table 1, shows the superior performance of these compounds.









TABLE 1







OIT values of various antioxidants in polyester based base stock.











OIT @ 200 ppm



Antioxidant
(min)













L 57
3



6PPD
22



V
36



A
37



II
32



I
115



X
28



XVIII
25





# OIT values were measured by DSC at 200° C. having Oxygen at 20 ml/min






The performance of antioxidants I, II, V, X, XVIII and A were also evaluated in polyolefins especially in polypropylene (PP) and are compared with the performance of commercially used antioxidant, Irganox 1010 (from Ciba, CAS # 6683-19-8). FIG. 3 shows the heat flow as a function time for extruded PP samples containing antioxidants at 1000 ppm level. These samples were prepared under identical processing conditions using a single screw extruder. oxidative induction time (OIT) was determined using ASTM D 3895-95, “Oxidative-Induction Time of Polyolefins by Differential Scanning calorimetry”.


Example 9
Increase Solubility of the Antioxidant V of the Present Invention in Group II Base Stock



embedded image


10 g of the antioxidant V was added to 90 g of Group II lubricant oil base stock in a beaker. The resultant mixture was stirred for 15 mins in a oil bath maintained at 60° C. to give a homogenous solution. This homogenous solution was used for evaluation. This solubility is much higher than the typical industry standards of 1-2%.


The entire contents of each of the following are incorporated herein by reference.

  • Provisional Patent Application No. 60/632,893, filed Dec. 3, 2004, Title: Process For The Synthesis Of Polyalkylphenol Antioxidants, by Suizhou Yang, et al;
  • Patent application Ser. No. 11/292,813 filed Dec. 2, 2005, Title: Process For The Synthesis Of Polyalkylphenol Antioxidants, by Suizhou Yang, et al;
  • Provisional Patent Application No. 60/633,197, filed Dec. 3, 2004, Title: Synthesis Of Sterically Hindered Phenol Based Macromolecular Antioxidants, by Ashish Dhawan, et al.;
  • Patent application Ser. No. 11/293,050; filed Dec. 2, 2005, Title: Synthesis Of Sterically Hindered Phenol Based Macromolecular Antioxidants, by Ashish Dhawan, et al.;
  • Provisional Patent Application. No. 60/633,252, filed Dec. 3, 2004, Title: One Pot Process For Making Polymeric Antioxidants, by Vijayendra Kumar, et al.;
  • Patent application Ser. No. 11/293,049; filed Dec. 2, 2005, Title: One Pot Process For Making Polymeric Antioxidants, by Vijayendra Kumar, et al.;
  • Provisional Patent Application No. 60/633,196, filed Dec. 3, 2004, Title: Synthesis Of Aniline And Phenol-Based Macromonomers And Corresponding Polymers, by Rajesh Kumar, et al.;
  • Patent application Ser. No. 11/293,844; filed Dec. 2, 2005, Title: Synthesis Of Aniline And Phenol-Based Macromonomers And Corresponding Polymers, by Rajesh Kumar, et al.;
  • Patent application Ser. No. 11/184,724, filed Jul. 19, 2005, Title: Anti-Oxidant Macromonomers And Polymers And Methods Of Making And Using The Same, by Ashok L. Cholli;
  • Patent application Ser. No. 11/184,716, filed Jul. 19, 2005, Title: Anti-Oxidant Macromonomers And Polymers And Methods Of Making And Using The Same, by Ashok L. Cholli;
  • Provisional Patent Application No. 60/655,169, filed Feb. 22, 2005, Title: Nitrogen And Hindered Phenol Containing Dual Functional Macromolecules: Synthesis And Their Antioxidant Performances In Organic Materials, by Rajesh Kumar, et al.
  • Provisional Patent Application No. 60/655,169, filed Mar. 25, 2005, Title: Alkylated Macromolecular Antioxidants And Methods Of Making, And Using The Same, by Rajesh Kumar, et al.
  • Provisional Patent Application No. 60/731,125, filed Oct. 27, 2005, Title: Macromolecular Antioxidants And Polymeric Macromolecular Antioxidants, by Ashok L. Cholli, et al.
  • Provisional Patent Application No. 60/731,021, filed Oct. 27, 2005, Title: Macromolecular Antioxidants Based On Sterically Hindered Phenols And Phosphites, by Ashok L. Cholli, et al.
  • Provisional Patent Application No. 60/742,150, filed Dec. 2, 2005, Title: Lubricant Composition, by Kumar, Rajesh, et al.
  • Provisional Patent Application No. 60/731,325, filed Oct. 27, 2005, Title: Stabilized Polyolefin Composition, by Kumar, Rajesh, et al.
  • Patent application Ser. No. 11/040,193, filed Jan. 21, 2005, Title: Post-Coupling Synthetic Approach For Polymeric Antioxidants, by Ashok L. Choll, et al.;
  • Patent Application No.: PCT/US200S/001948, filed Jan. 21, 2005, Title: Post-Coupling Synthetic Approach For Polymeric Antioxidants, by Ashok L. Cholli et al.;
  • Patent Application No.: PCT/US2005/001946, filed Jan. 21, 2005, Title: Polymeric Antioxidants, by Ashok L. Choll, et al.;
  • Patent Application No.: PCT/US03/10782, filed Apr. 4, 2003, Title: Polymeric Antioxidants, by Ashok L. Choll, et al.;
  • Patent application Ser. No. 10/761,933, filed Jan. 21, 2004, Title: Polymeric Antioxidants, by Ashish Dhawan, et al.;
  • Patent application Ser. No. 10/408,679, filed Apr. 4, 2003, Title: Polymeric Antioxidants, by Ashok L. Choll, et al.;
  • US patent No.: U.S. Pat. No. 6,770,785 B1
  • US patent No.: U.S. Pat. No. 5,834,544
  • Neftekhimiya (1981), 21(2): 287-298.


While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in faun and details may be made therein without departing from the scope of the invention.


EQUIVALENTS

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to specific embodiments of the invention described specifically herein. Such equivalents are intended to be encompassed in the scope of the following claims.

Claims
  • 1. A compound represented by the following structural formula:
RELATED APPLICATION

This application is a divisional of U.S. application Ser. No. 11/360,020, filed Feb. 22, 2006 now U.S. Pat. No. 7,799,948, which claims the benefit of U.S. Provisional Application No. 60/655,169, filed on Feb. 22, 2005. The entire teachings of the above applications are incorporated herein by reference.

US Referenced Citations (157)
Number Name Date Kind
3116305 Morris et al. Dec 1963 A
3294836 Peterson et al. Dec 1966 A
3441545 Blatz et al. Apr 1969 A
3459704 Peterson et al. Aug 1969 A
3557245 Phillips et al. Jan 1971 A
3632785 Bornstein Jan 1972 A
3645970 Kleiner Feb 1972 A
3649667 Song et al. Mar 1972 A
3655831 Friedman Apr 1972 A
3870680 Schurdak Mar 1975 A
3907939 Robin et al. Sep 1975 A
3953402 Kline Apr 1976 A
3965039 Chaplits et al. Jun 1976 A
3983091 Gloth et al. Sep 1976 A
3994828 Zaffaroni Nov 1976 A
3996160 Dale et al. Dec 1976 A
3996198 Wang et al. Dec 1976 A
4054676 Weinshenker et al. Oct 1977 A
4094857 Wolfe, Jr. Jun 1978 A
4096319 Willette et al. Jun 1978 A
4097464 Kline Jun 1978 A
4098829 Weinshenker et al. Jul 1978 A
4107144 Russell et al. Aug 1978 A
4136055 Lyons Jan 1979 A
4202816 Moser et al. May 1980 A
4205151 Dale et al. May 1980 A
4213892 Scott Jul 1980 A
4219453 Sakurai et al. Aug 1980 A
4267358 Hechenbleikner et al. May 1981 A
4281192 Jacquet et al. Jul 1981 A
4283572 Klicker Aug 1981 A
4317933 Parker Mar 1982 A
4341879 Sugio et al. Jul 1982 A
4355148 Layer et al. Oct 1982 A
4377666 Farrar Mar 1983 A
4380554 Serres, Jr. Apr 1983 A
4447657 Firth et al. May 1984 A
4465871 Firth et al. Aug 1984 A
4510296 Hergenrother Apr 1985 A
4511491 Ishii et al. Apr 1985 A
4634728 Dunski et al. Jan 1987 A
4690995 Keskey et al. Sep 1987 A
4761247 Rei et al. Aug 1988 A
4824929 Arimatsu et al. Apr 1989 A
4849503 Cotter et al. Jul 1989 A
4855345 Rosenberger et al. Aug 1989 A
4857596 MacLeay et al. Aug 1989 A
4870214 Mina et al. Sep 1989 A
4894263 Dubois et al. Jan 1990 A
4897438 Kikuchi et al. Jan 1990 A
4900671 Pokora et al. Feb 1990 A
4925591 Nakauchi et al. May 1990 A
4968759 Kikuchi et al. Nov 1990 A
4977004 Bettle, III et al. Dec 1990 A
4981917 MacLeay et al. Jan 1991 A
4994628 Goddard et al. Feb 1991 A
5013470 Benfaremo May 1991 A
5017727 Olivier May 1991 A
5082358 Tabata et al. Jan 1992 A
5102962 Kikuchi et al. Apr 1992 A
5117063 Stern et al. May 1992 A
5143828 Akkara et al. Sep 1992 A
5155153 Neri et al. Oct 1992 A
5185391 Stokich, Jr. Feb 1993 A
5185407 Wong Feb 1993 A
5188953 Johnson et al. Feb 1993 A
5191008 Frost et al. Mar 1993 A
5196142 Mollet et al. Mar 1993 A
5206303 Tse et al. Apr 1993 A
5207939 Farng et al. May 1993 A
5274060 Schadeli Dec 1993 A
5278055 Cyrus, Jr. et al. Jan 1994 A
5304589 Davidson et al. Apr 1994 A
5320889 Bettle, III Jun 1994 A
5449715 Plochocka et al. Sep 1995 A
5498809 Emert et al. Mar 1996 A
RE35247 Cyrus, Jr. et al. May 1996 E
5516856 Sanchez May 1996 A
5541091 Wheeler et al. Jul 1996 A
5565300 Uenishi et al. Oct 1996 A
5574118 Olivier Nov 1996 A
5652201 Papay et al. Jul 1997 A
5739341 Dubs et al. Apr 1998 A
5834544 Lin et al. Nov 1998 A
5837798 Hutchings et al. Nov 1998 A
5869592 Gagne et al. Feb 1999 A
5911937 Hekal Jun 1999 A
5994498 Tripathy et al. Nov 1999 A
6018018 Samuelson et al. Jan 2000 A
6046263 Rasberger et al. Apr 2000 A
6096695 Lam et al. Aug 2000 A
6096859 Akkara et al. Aug 2000 A
6150491 Akkara Nov 2000 A
6232314 Jarrott et al. May 2001 B1
6342549 Hirose et al. Jan 2002 B1
6444450 Akkara et al. Sep 2002 B2
6646035 Koch et al. Nov 2003 B2
6723815 Callaghan et al. Apr 2004 B2
6743525 Berntsen et al. Jun 2004 B2
6770785 Desai et al. Aug 2004 B1
6794480 Goto et al. Sep 2004 B2
6800228 Semen Oct 2004 B1
6828364 Gugumus Dec 2004 B2
7132496 Kerres et al. Nov 2006 B2
7169844 Inokami Jan 2007 B2
7205350 Thibaut Apr 2007 B2
7223432 Cholli et al. May 2007 B2
7262319 Rehm et al. Aug 2007 B2
7705176 Cholli et al. Apr 2010 B2
20010041203 Uno et al. Nov 2001 A1
20020007020 Higashimura et al. Jan 2002 A1
20020128493 Romanczyk, Jr. et al. Sep 2002 A1
20020143025 Pratt et al. Oct 2002 A1
20020183470 Tripathy et al. Dec 2002 A1
20030030033 Duyck et al. Feb 2003 A1
20030078346 Nakamura et al. Apr 2003 A1
20030091837 Aoki May 2003 A1
20030176620 Romanczyk, Jr. et al. Sep 2003 A1
20030191242 Zedda et al. Oct 2003 A1
20030229196 Braat et al. Dec 2003 A1
20030230743 Cholli et al. Dec 2003 A1
20040015021 Adams et al. Jan 2004 A1
20040164279 Stevenson et al. Aug 2004 A1
20040180994 Pearson et al. Sep 2004 A1
20040186167 Dou et al. Sep 2004 A1
20040186214 Li et al. Sep 2004 A1
20040198875 Kaprinidis et al. Oct 2004 A1
20040214935 Cholli et al. Oct 2004 A1
20050170978 Migdal et al. Aug 2005 A1
20050209379 Botkin et al. Sep 2005 A1
20050238789 Cholli et al. Oct 2005 A1
20050242328 Baranski Nov 2005 A1
20060029706 Cholli et al. Feb 2006 A1
20060040833 Al-Akhdar et al. Feb 2006 A1
20060041087 Cholli Feb 2006 A1
20060041094 Cholli Feb 2006 A1
20060128929 Yang et al. Jun 2006 A1
20060128930 Dhawan et al. Jun 2006 A1
20060128931 Kumar et al. Jun 2006 A1
20060128939 Kumar et al. Jun 2006 A1
20060154818 Destro et al. Jul 2006 A1
20060189820 Rehm et al. Aug 2006 A1
20060189824 Kumar et al. Aug 2006 A1
20060208227 Shiraki Sep 2006 A1
20060233741 Kumar et al. Oct 2006 A1
20070010632 Kaplan et al. Jan 2007 A1
20070106059 Cholli et al. May 2007 A1
20070135539 Cholli et al. Jun 2007 A1
20070149660 Kumar et al. Jun 2007 A1
20070154430 Cholli et al. Jul 2007 A1
20070154608 Cholli et al. Jul 2007 A1
20070154720 Cholli et al. Jul 2007 A1
20070161522 Cholli et al. Jul 2007 A1
20080249335 Cholli et al. Oct 2008 A1
20080293856 Kumar et al. Nov 2008 A1
20080311065 Cholli Dec 2008 A1
20090184294 Cholli et al. Jul 2009 A1
Foreign Referenced Citations (59)
Number Date Country
111291 Jun 1964 CS
197 47 644 May 1999 DE
198 43 875 Mar 2000 DE
0 181 023 May 1986 EP
0 289 077 Nov 1988 EP
0 358 157 Mar 1990 EP
0 404 039 Dec 1990 EP
0 618 203 Oct 1994 EP
0 688 805 Dec 1995 EP
1 067 144 Jan 2001 EP
1 468 968 Oct 2004 EP
2 183 973 Dec 1973 FR
1042639 Sep 1964 GB
1 283 103 Jul 1972 GB
1 320 169 Jun 1973 GB
1 372 042 Oct 1974 GB
1 389 442 Apr 1975 GB
1 469 245 Apr 1977 GB
1 482 649 Aug 1977 GB
69002715 Jan 1966 JP
43016392 Jul 1968 JP
44024274 Oct 1969 JP
44028850 Nov 1969 JP
45 2980 Jan 1970 JP
49 29339 Mar 1974 JP
57085366 May 1982 JP
59025814 Feb 1984 JP
59197447 Nov 1984 JP
60-199832 Oct 1985 JP
05 199858 Aug 1993 JP
06135876 May 1994 JP
06 247959 Sep 1994 JP
08027226 Jan 1996 JP
09262069 Oct 1997 JP
09 328519 Dec 1997 JP
09 328521 Dec 1997 JP
9322784 Dec 1997 JP
11-80063 Mar 1999 JP
11-158103 Jun 1999 JP
2003138258 May 2003 JP
7 905 000 Mar 1980 NL
WO 9220734 Nov 1992 WO
WO 0039064 Jul 2000 WO
WO 0118125 Mar 2001 WO
WO 0148057 Jul 2001 WO
WO 02079130 Oct 2002 WO
WO 03087260 Oct 2003 WO
WO 03102004 Dec 2003 WO
WO 2004024070 Mar 2004 WO
WO 2004050795 Jun 2004 WO
WO 2005025513 Mar 2005 WO
WO 2005025646 Mar 2005 WO
WO 2005060500 Jul 2005 WO
WO 2005070974 Aug 2005 WO
WO 2005071005 Aug 2005 WO
WO 2006018403 Feb 2006 WO
WO 2006060801 Jun 2006 WO
WO 2006104957 Oct 2006 WO
WO 2008005358 Jan 2008 WO
Related Publications (1)
Number Date Country
20110040125 A1 Feb 2011 US
Provisional Applications (1)
Number Date Country
60655169 Feb 2005 US
Divisions (1)
Number Date Country
Parent 11360020 Feb 2006 US
Child 12854347 US